BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31432556)

  • 1. Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial.
    Khalil A; Sharp A; Cornforth C; Jackson R; Mousa H; Stock S; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Von Dadelszen P; Magee L; Papageorghiou AT; Alfirevic Z
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):198-209. PubMed ID: 31432556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small-for-gestational-age fetus?
    Perry H; Lehmann H; Mantovani E; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):210-216. PubMed ID: 31381215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.
    Pels A; Derks J; Elvan-Taspinar A; van Drongelen J; de Boer M; Duvekot H; van Laar J; van Eyck J; Al-Nasiry S; Sueters M; Post M; Onland W; van Wassenaer-Leemhuis A; Naaktgeboren C; Jakobsen JC; Gluud C; Duijnhoven RG; Lely T; Gordijn S; Ganzevoort W;
    JAMA Netw Open; 2020 Jun; 3(6):e205323. PubMed ID: 32585017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.
    Sharp A; Cornforth C; Jackson R; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Khalil A; von Dadelszen P; Papageorghiou AT; Alfirevic Z;
    Lancet Child Adolesc Health; 2018 Feb; 2(2):93-102. PubMed ID: 30169244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations.
    von Dadelszen P; Audibert F; Bujold E; Bone JN; Sandhu A; Li J; Kariya C; Chung Y; Lee T; Au K; Skoll MA; Vidler M; Magee LA; Piedboeuf B; Baker PN; Lalji S; Lim KI
    BMC Res Notes; 2022 Jul; 15(1):244. PubMed ID: 35799272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction.
    Pels A; Jakobsen JC; Ganzevoort W; Naaktgeboren CA; Onland W; van Wassenaer-Leemhuis AG; Gluud C
    Trials; 2019 Jan; 20(1):42. PubMed ID: 30635020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices.
    Trapani A; Gonçalves LF; Trapani TF; Franco MJ; Galluzzo RN; Pires MM
    Ultrasound Obstet Gynecol; 2016 Jul; 48(1):61-5. PubMed ID: 26279411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.
    Groom KM; McCowan LM; Mackay LK; Lee AC; Gardener G; Unterscheider J; Sekar R; Dickinson JE; Muller P; Reid RA; Watson D; Welsh A; Marlow J; Walker SP; Hyett J; Morris J; Stone PR; Baker PN
    BJOG; 2019 Jul; 126(8):997-1006. PubMed ID: 30779295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.
    El-Sayed MA; Saleh SA; Maher MA; Khidre AM
    J Matern Fetal Neonatal Med; 2018 Apr; 31(8):1045-1050. PubMed ID: 28345432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial.
    Shehata NAA; Ali HAA; Fahim AS; Katta MA; Hussein GK
    J Matern Fetal Neonatal Med; 2020 May; 33(10):1631-1637. PubMed ID: 30345864
    [No Abstract]   [Full Text] [Related]  

  • 11. Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction.
    Roberts LA; Ling HZ; Poon LC; Nicolaides KH; Kametas NA
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):507-514. PubMed ID: 29607557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal sildenafil treatment improves neonatal pulmonary hemodynamics and gas exchange in lambs with diaphragmatic hernia.
    Kashyap AJ; Dekoninck PLJ; Rodgers KA; Thio M; Mcgillick EV; Amberg BJ; Skinner SM; Moxham AM; Russo FM; Deprest JA; Hooper SB; Crossley KJ; Hodges RJ
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):506-516. PubMed ID: 31364206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012).
    ; Martins JG; Biggio JR; Abuhamad A
    Am J Obstet Gynecol; 2020 Oct; 223(4):B2-B17. PubMed ID: 32407785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal plasma soluble neuropilin-1 is downregulated in fetal growth restriction complicated by abnormal umbilical artery Doppler: a pilot study.
    Porter B; Maulik D; Babbar S; Schrufer-Poland T; Allsworth J; Ye SQ; Heruth DP; Lei T
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):716-721. PubMed ID: 33533520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes in vascular function parameters in pregnant women with chronic hypertension and association with adverse outcome: a cohort study.
    Webster LM; Myers JE; Nelson-Piercy C; Mills C; Watt-Coote I; Khalil A; Seed PT; Cruickshank JK; Chappell LC
    Ultrasound Obstet Gynecol; 2019 May; 53(5):638-648. PubMed ID: 29380922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal and Hemodynamic Evaluation of Sildenafil Citrate for Preeclampsia Treatment: A Randomized Controlled Trial.
    Trapani A; Gonçalves LF; Trapani TF; Vieira S; Pires M; Pires MMS
    Obstet Gynecol; 2016 Aug; 128(2):253-259. PubMed ID: 27400005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial.
    Maged M; Wageh A; Shams M; Elmetwally A
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):483-486. PubMed ID: 30122565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal sildenafil citrate treatment increases offspring blood pressure in the placental-specific
    Renshall LJ; Cottrell EC; Cowley E; Sibley CP; Baker PN; Thorstensen EB; Greenwood SL; Wareing M; Dilworth MR
    Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H252-H263. PubMed ID: 31809211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis.
    Ganzevoort W; Alfirevic Z; von Dadelszen P; Kenny L; Papageorghiou A; van Wassenaer-Leemhuis A; Gluud C; Mol BW; Baker PN
    Syst Rev; 2014 Mar; 3():23. PubMed ID: 24618418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Administration of Sildenafil Citrate Alters Fetal and Placental Growth and Fetal-Placental Vascular Resistance in the Growth-Restricted Ovine Fetus.
    Oyston C; Stanley JL; Oliver MH; Bloomfield FH; Baker PN
    Hypertension; 2016 Sep; 68(3):760-7. PubMed ID: 27432857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.